Henry Schein Medical to offer Atossa Genetics' FullCYTE Breast Aspirator Earlier today, Atossa Genetics (ATOS) announced that Henry Schein Medical, the U.S. Medical business of Henry Schein (HSIC), will offer its customers the FullCYTE Breast Aspirator. The Atossa FullCYTE Breast Aspirator is used by OB/GYNs, primary care physicians and women's clinics to collect fluid from breasts for subsequent cytological evaluation. Dr. Steven C. Quay, Chairman, President & CEO of Atossa Genetics, commented, "Working with Henry Schein is an important step forward in making the FullCYTE Breast Aspirator available nationwide. Henry Schein is an industry leader and its multi-channel sales organization allows for expanded reach into multiple market segments within health care for our device. We are thrilled to work with a company such as Henry Schein and believe our arrangement will contribute positively to our upcoming nationwide launch." Shares of Atossa Genetics are up almost 48% in morning trading.